PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:20 AM ET

Sponsor Check › Person

MG
No photo found yet (own website and image search run after this page is viewed)

Michael Grey

Named as an officer, director or promoter on SEC Form D filings · CA, NC, IL, UT, CO · Aug 3, 2009 → Jan 29, 2026

10deals (issuers)
$635.7Mreported sold
232investors
29Form D filings
2009–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:17 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Michael Grey is listed as an executive officer and director on 29 SEC Form D filings by 10 issuers between Aug 2009 and Jan 2026. Largest by amount reported sold: HORIZON PHARMA, INC. (Deerfield, IL — pharmaceuticals — 2012–2013; $150M reported sold to 74 investors), Amplyx Pharmaceuticals, Inc. (San Diego, CA — pharmaceuticals — 2015–2020; $91.3M reported sold to 28 investors), SPRUCE BIOSCIENCES, INC. (South San Francisco, CA — biotechnology — 2020–2025; $88M reported sold to 21 investors), Mirum Pharmaceuticals, Inc. (Foster City, CA — biotechnology — 2018–2026; $68.5M reported sold to 14 investors), OnKure Therapeutics, Inc. (Boulder, CO — pharmaceuticals — 2018–2024; $65M reported sold to 20 investors) and 5 more (all listed below).

What this means That is a lot of deals — 10 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $635.7M sold in total.

Listed alongside Ed Mathers (6 shared filings), Edward Mathers (6 shared filings), Bali Muralidhar (5 shared filings), Ciara Kennedy (5 shared filings), Tiba Aynechi (5 shared filings) and 95 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.

1 of the issuers belongs to the sponsor group Onkure (2 issuers, $118.8M reported sold, 2011–2024).

What this means A sponsor group is one team that sets up a new company for each deal. Onkure has 2 companies on file and $118.8M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 16 bankruptcy cases matching the name listed in Key records below.

What this means 16 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 29 public filings for Michael Grey and found 15 differences, 5 worth asking the sponsor about: Regulator action naming a team member: Sepehr Sarshar (May 9, 2022); Regulator action naming a team member: Sepehr Sarshar (Aug 25, 2020); and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Michael Grey has not run yet — it is #1,026 of 30,896 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:17 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Michael Grey..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

16 cases: 16 closed (disposition not in docket feed)

Michael L Grey closed
United States Bankruptcy Court, S.D. Mississippi · No. 24-01631 · Filed Jul 16, 2024 · Closed Dec 2, 2024
Role of Michael L Grey: Debtor · Outcome: Case closed 2024-12-02 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in MS (not a filing state)
Michael N Grey closed
United States Bankruptcy Court, C.D. California · No. 6:19-bk-13837 · Filed May 3, 2019 · Closed Aug 13, 2019
Role of Michael N Grey: Debtor · Outcome: Case closed 2019-08-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in the person's filing state (CA)
Michael D Grey and Helen S Grey closed
United States Bankruptcy Court, W.D. Kentucky · No. 09-35488 · Filed Oct 27, 2009 · Closed Feb 3, 2010
Role of Michael D Grey and Helen S Grey: Debtor · Outcome: Case closed 2010-02-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in KY (not a filing state)
Michael D Grey closed
United States Bankruptcy Court, W.D. New York · No. 1-06-01006 · Filed Apr 28, 2006 · Closed Aug 7, 2006
Role of Michael D Grey: Debtor · Outcome: Case closed 2006-08-07 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in NY (not a filing state)
Michael T. Grey closed
United States Bankruptcy Court, S.D. Illinois · No. 04-34252 · Filed Oct 21, 2004 · Closed Jan 28, 2005
Role of Michael T. Grey: Debtor · Outcome: Case closed 2005-01-28 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in the person's filing state (IL)
Michael M Grey closed
United States Bankruptcy Court, C.D. California · No. 8:02-bk-13152 · Filed Apr 23, 2002 · Closed Jun 30, 2006
Role of Michael M Grey: Debtor · Outcome: Case closed 2006-06-30 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in the person's filing state (CA)
Michael L. Grey and Wendy M. Grey closed
United States Bankruptcy Court, N.D. Mississippi · No. 99-14626 · Filed Oct 19, 1999 · Closed Feb 23, 2000
Role of Michael L. Grey and Wendy M. Grey: Debtor · Outcome: Case closed 2000-02-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in MS (not a filing state)
Michael J. Grey closed
United States Bankruptcy Court, D. New Jersey · No. 99-35558 · Filed May 14, 1999 · Closed Sep 14, 1999
Role of Michael J. Grey: Debtor · Outcome: Case closed 1999-09-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in NJ (not a filing state)
Michael Grey closed
United States Bankruptcy Court, D. New Jersey · No. 98-51821 · Filed Sep 15, 1998 · Closed Dec 31, 1998
Role of Michael Grey: Debtor · Outcome: Case closed 1998-12-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in NJ (not a filing state)
Michael A. Grey and Carmen M. Grey closed
United States Bankruptcy Court, E.D. Pennsylvania · No. 98-11254 · Filed Jan 30, 1998 · Closed Mar 4, 1998
Role of Michael A. Grey and Carmen M. Grey: Debtor · Outcome: Case closed 1998-03-04 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in PA (not a filing state)
Michael G. Grey closed
United States Bankruptcy Court, C.D. California · No. 8:97-bk-16607 · Filed Apr 30, 1997 · Closed Jul 24, 1997
Role of Michael G. Grey: Debtor · Outcome: Case closed 1997-07-24 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in the person's filing state (CA)
Michele A. Grey and Michael A. Grey closed
United States Bankruptcy Court, S.D. Florida. · No. 96-24738 · Filed Oct 1, 1996 · Closed May 31, 2000
Role of Michael A. Grey: Debtor · Outcome: Case closed 2000-05-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in FL (not a filing state)
MICHAEL GREY closed
United States Bankruptcy Court, D. Arizona · No. 0:95-bk-10723 · Filed Nov 20, 1995 · Closed Jun 26, 1998
Role of MICHAEL GREY: Debtor · Outcome: Case closed 1998-06-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in AR (not a filing state)
Michael Grey closed
United States Bankruptcy Court, N.D. Ohio · No. 95-12010 · Filed May 8, 1995 · Closed Aug 29, 1995
Role of Michael Grey: Debtor · Outcome: Case closed 1995-08-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in OH (not a filing state)
Michael J. Grey closed
United States Bankruptcy Court, E.D. Wisconsin · No. 94-20081 · Filed Jan 7, 1994 · Closed Apr 13, 1994
Role of Michael J. Grey: Debtor · Outcome: Case closed 1994-04-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in WI (not a filing state)
Michael W. Grey and Ann Marie Grey closed
United States Bankruptcy Court, N.D. New York · No. 93-61169 · Filed Apr 15, 1993 · Closed Oct 20, 1993
Role of Michael W. Grey and Ann Marie Grey: Debtor · Outcome: Case closed 1993-10-20 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 31 federal dockets); 3 people with this name in Form D filings; court in NY (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:17 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

15 differences found between the filings for Michael Grey — 5 worth asking about (compared 29 filings on Oct 24, 2026)

Worth asking · May 9, 2022

Regulator action naming a team member: Sepehr Sarshar (May 9, 2022)

An SEC litigation release dated May 9, 2022 names Sep Sarshar (listed on the same filings). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Sepehr Sarshar ↗Sep Sarshar — PartnerFacts page ↗
Sources
Worth asking · Aug 25, 2020

Regulator action naming a team member: Sepehr Sarshar (Aug 25, 2020)

An SEC litigation release dated Aug 25, 2020 names Sep Sarshar (listed on the same filings). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

Sepehr Sarshar ↗Sep Sarshar — PartnerFacts page ↗
Sources
Worth asking · Aug 3, 2009 – Oct 22, 2009

Amount sold went down between filings — Auspex Pharmaceuticals, Inc.

The Aug 3, 2009 filing says $3,000,000 sold; the Oct 22, 2009 Form D says $2,000,000 sold — $1,000,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Aug 3, 2009 ↗Form D (later) · Oct 22, 2009 ↗Auspex Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Aug 3, 2009 – Oct 22, 2009

Investor count went down between filings — Auspex Pharmaceuticals, Inc.

The Aug 3, 2009 filing reports 7 investors; the Oct 22, 2009 Form D reports 5 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Aug 3, 2009 ↗Form D (later) · Oct 22, 2009 ↗Auspex Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · May 22, 2009 – Aug 25, 2025

8 Form Ds were filed more than 15 days after the first sale

Form D filed 73 days after the first sale — Auspex Pharmaceuticals, Inc. · Form D filed 42 days after the first sale — Plexium, Inc. · Form D filed 17 days after the first sale — OnKure Therapeutics, Inc. · Form D filed 21 days after the first sale — Sorriso Pharmaceuticals, Inc. · Form D filed 17 days after the first sale — OnKure Therapeutics, Inc. · and 3 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Aug 3, 2009 ↗Auspex Pharmaceuticals, Inc. — PartnerFacts page ↗Form D · Aug 25, 2025 ↗Plexium, Inc. — PartnerFacts page ↗
Sources
Note · Oct 29, 2015 – Jan 11, 2022

6 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Sorriso Pharmaceuticals, Inc. (latest filing Jan 11, 2022) · No amendment in the last 12 months on an offering that may still be open — OnKure Therapeutics, Inc. (latest filing Dec 21, 2020) · No amendment in the last 12 months on an offering that may still be open — Amplyx Pharmaceuticals, Inc. (latest filing Jan 9, 2020) · No amendment in the last 12 months on an offering that may still be open — Mirum Pharmaceuticals, Inc. (latest filing Nov 20, 2018) · No amendment in the last 12 months on an offering that may still be open — OnKure Therapeutics, Inc. (latest filing Jan 8, 2018) · and 1 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jan 11, 2022 ↗Sorriso Pharmaceuticals, Inc. — PartnerFacts page ↗Form D · Dec 21, 2020 ↗OnKure Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Aug 1, 2017 – Feb 28, 2023

4 role changes for the same people across filings

Michael Grey's role changed at SPRUCE BIOSCIENCES, INC.: director → executive officer, director · Michael Grey's role changed at Mirum Pharmaceuticals, Inc.: executive officer, director → director · Michael Grey's role changed at Amplyx Pharmaceuticals, Inc.: executive officer, director → director · Michael Grey's role changed at OnKure Therapeutics, Inc.: executive officer, director → director

What this means Roles on Form D are self-reported. Ask who runs the company today.

Form D/A · Aug 14, 2020 ↗Form D · Feb 28, 2023 ↗Michael Grey — PartnerFacts page ↗SPRUCE BIOSCIENCES, INC. — PartnerFacts page ↗
Sources
Note · Aug 3, 2009 – Jan 9, 2020

6 offerings changed their target amount between filings

Offering amount changed between filings — Amplyx Pharmaceuticals, Inc. · Offering amount changed between filings — Amplyx Pharmaceuticals, Inc. · Offering amount changed between filings — Lumena Pharmaceuticals, Inc. · Offering amount changed between filings — Lumena Pharmaceuticals, Inc. · Offering amount changed between filings — Lumena Pharmaceuticals, Inc. · and 1 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Aug 1, 2017 ↗Form D/A (later) · Jan 9, 2020 ↗Amplyx Pharmaceuticals, Inc. — PartnerFacts page ↗Form D (earlier) · Nov 12, 2015 ↗
Sources
Note · Aug 3, 2009 – Dec 30, 2020

Michael Grey is written 2 different ways on the filings

listed as "Michael Grey" on 27 filings (from Aug 3, 2009), and "Michael G. Grey" on 2 filings (from Dec 30, 2020).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Aug 3, 2009 ↗Form D · Dec 30, 2020 ↗Michael Grey — PartnerFacts page ↗
Sources
Note · Nov 20, 2018 – Jan 29, 2026

Industry group changed between filings — Mirum Pharmaceuticals, Inc.

"Pharmaceuticals" (Nov 20, 2018 to Dec 30, 2020); then "Biotechnology" (Jan 29, 2026).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Nov 20, 2018 ↗Form D · Jan 29, 2026 ↗Mirum Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Feb 28, 2020 – Feb 28, 2023

Reported revenue range changed between filings — SPRUCE BIOSCIENCES, INC.

"Not Applicable" (Feb 28, 2020); then "No Revenues" (Feb 28, 2023).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Feb 28, 2020 ↗Form D · Feb 28, 2023 ↗SPRUCE BIOSCIENCES, INC. — PartnerFacts page ↗
Sources
Note · Nov 29, 2011

Same name, different state: "Michael Grey" (MA) is a separate record

This page covers filings where the address state is CA or NC or IL or UT or CO. A separate record, "Michael Grey" with address state MA, is listed on 1 filing — most recently by Selventa, Inc. (Nov 29, 2011). Both records have filings in the same period (Nov 29, 2011).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Michael Grey (MA) — PartnerFacts page ↗Form D · Nov 29, 2011 ↗Selventa, Inc. — PartnerFacts page ↗Michael Grey (CA,NC,IL,UT,CO) — this page ↗
Sources
Note · Aug 23, 2010

Same name, different state: "Michael Grey" (CT) is a separate record

This page covers filings where the address state is CA or NC or IL or UT or CO. A separate record, "Michael Grey" with address state CT, is listed on 1 filing — most recently by ACHILLION PHARMACEUTICALS INC (Aug 23, 2010). Both records have filings in the same period (Aug 23, 2010).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Michael Grey (CT) — PartnerFacts page ↗Form D · Aug 23, 2010 ↗ACHILLION PHARMACEUTICALS INC — PartnerFacts page ↗Michael Grey (CA,NC,IL,UT,CO) — this page ↗
Sources
Note · May 24, 2012 – Oct 21, 2024

5 address changes between filings

Address moved from San Diego, CA to Boulder, CO — OnKure Therapeutics, Inc. · Address moved from Daly City, CA to South San Francisco, CA — SPRUCE BIOSCIENCES, INC. · Address moved from San Diego, CA to Foster City, CA — Mirum Pharmaceuticals, Inc. · Address moved from San Francisco, CA to Daly City, CA — SPRUCE BIOSCIENCES, INC. · Address moved from Durham, NC to San Diego, CA — Lumena Pharmaceuticals, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Dec 21, 2020 ↗Form D · Oct 21, 2024 ↗OnKure Therapeutics, Inc. — PartnerFacts page ↗Form D/A · Aug 14, 2020 ↗
Sources
Note · Aug 3, 2009 – Jan 29, 2026

Michael Grey is listed with 5 different address states: CA, NC, IL, UT, CO

CA on 20 filings (Aug 3, 2009 to Jan 29, 2026); NC on 4 filings (Feb 17, 2011 to May 24, 2012); IL on 3 filings (Mar 8, 2012 to Dec 9, 2013); UT on 1 filing (Jan 11, 2022); CO on 1 filing (Oct 21, 2024).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Aug 3, 2009 ↗Form D · Feb 17, 2011 ↗Form D · Mar 8, 2012 ↗Form D · Jan 11, 2022 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

6 of 23 offerings report sales commissions totalling $20,811,803; 1 reports finder's fees totalling $598,594; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jan 29, 2026 D
Mirum Pharmaceuticals, Inc.
File 021-571698
$0$0$0None listed on this filingEDGAR ↗
Oct 17, 2025 D
SPRUCE BIOSCIENCES, INC.
File 021-561207
$3,000,000$0$0
The Company shall use the net proceeds of the sale of the Securities hereunder for non-clinical and clinical development activities for its product candidate, pre-commercial activities and general corporate purposes.
Leerink Partners LLC BrokerCheck CRD 39011 ↗
Citizens JMP Securities, LLC BrokerCheck CRD 22208 ↗
H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗		EDGAR ↗
Aug 25, 2025 D
Plexium, Inc.
File 021-555722
$0$0$0None listed on this filingEDGAR ↗
Oct 21, 2024 D
OnKure Therapeutics, Inc.
File 021-527340
$3,250,000$0$0Evercore Group, L.L.C BrokerCheck CRD 42405 ↗
Leerlink Partners LLC BrokerCheck CRD 39011 ↗
LifeSci Capital, LLC BrokerCheck CRD 168404 ↗		EDGAR ↗
Feb 28, 2023 D
SPRUCE BIOSCIENCES, INC.
File 021-474453
$2,437,603$0$0 (est.)
The Company shall use the net proceeds of the sale of the securities for non-clinical and clinical development activities for its product candidate, pre-commercial activities and general corporate purposes.
SVB Securities LLC BrokerCheck CRD 39011 ↗EDGAR ↗
Jan 11, 2022 D
Sorriso Pharmaceuticals, Inc.
File 021-428887
$0$0$0None listed on this filingEDGAR ↗
Dec 30, 2020 D
Mirum Pharmaceuticals, Inc.
File 021-384864
$0$0$0None listed on this filingEDGAR ↗
Dec 21, 2020 D
OnKure Therapeutics, Inc.
File 021-383843
$0$0$0None listed on this filingEDGAR ↗
Aug 14, 2020 D/A
SPRUCE BIOSCIENCES, INC.
File 021-361655
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 9, 2020 D/A
Amplyx Pharmaceuticals, Inc.
File 021-291889
$0$0$0None listed on this filingEDGAR ↗
May 14, 2019 D
OnKure Therapeutics, Inc.
File 021-339502
$0$0$0None listed on this filingEDGAR ↗
Nov 20, 2018 D
Mirum Pharmaceuticals, Inc.
File 021-326260
$0$0$0None listed on this filingEDGAR ↗
Jan 8, 2018 D
OnKure Therapeutics, Inc.
File 021-302643
$0$0$0None listed on this filingEDGAR ↗
Dec 24, 2015 D/A
Amplyx Pharmaceuticals, Inc.
File 021-251044
$0$0$0None listed on this filingEDGAR ↗
May 19, 2015 D
Balance Therapeutics, Inc.
File 021-240194
$0$0$0None listed on this filingEDGAR ↗
May 5, 2015 D
Balance Therapeutics, Inc.
File 021-239210
$0$0$0None listed on this filingEDGAR ↗
Mar 19, 2015 D
Balance Therapeutics, Inc.
File 021-236214
$0$598,594$0LWPartners Capital Group LLC BrokerCheck CRD 167438 ↗EDGAR ↗
Mar 19, 2014 D
Lumena Pharmaceuticals, Inc.
File 021-213918
$0$0$0None listed on this filingEDGAR ↗
Dec 9, 2013 D
HORIZON PHARMA, INC.
File 021-207631
$6,000,000$0$0JMP Securities LLC BrokerCheck CRD 22208 ↗
via JMP Securities LLC (CRD 22208 ↗)

Cowen and Company, LLC BrokerCheck CRD 7616 ↗
via Cowen and Company, LLC (CRD 7616 ↗)
EDGAR ↗
May 24, 2012 D/A
Lumena Pharmaceuticals, Inc.
File 021-155528
$0$0$0None listed on this filingEDGAR ↗
Mar 19, 2012 D
HORIZON PHARMA, INC.
File 021-175137
$3,124,200$0$0JMP Securities, LLC BrokerCheck CRD 22208 ↗
via JMP Securities, LLC (CRD 22208 ↗)

Cowen & Company LLC BrokerCheck CRD 7616 ↗
via Cowen & Company LLC (CRD 7616 ↗)

Stifel, Nicolaus & Company Incorporated BrokerCheck CRD 793 ↗
via Stifel, Nicolaus & Company Incorporated (CRD 793 ↗)
EDGAR ↗
Mar 8, 2012 D
HORIZON PHARMA, INC.
File 021-174559
$3,000,000$0$0JMP Securities, LLC BrokerCheck CRD 22208 ↗
via JMP Securities, LLC (CRD 22208 ↗)

Cowen & Company LLC BrokerCheck CRD 7616 ↗
via Cowen & Company LLC (CRD 7616 ↗)

Stifel, Nicolaus & Company Incorporated BrokerCheck CRD 793 ↗
via Stifel, Nicolaus & Company Incorporated (CRD 793 ↗)
EDGAR ↗
Aug 3, 2009 D
Auspex Pharmaceuticals, Inc.
File 021-126470
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 10

Every issuer that named Michael Grey on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

MP
Biotechnology

Mirum Pharmaceuticals, Inc.

Foster City, CA · Nov 20, 2018 → Jan 29, 2026 · 3 filings
  • Jan 29, 2026 · D · $68,480,000 sold of $68,480,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 30, 2020 · D · $10,000,000 sold of $10,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 20, 2018 · D · $60,063,750 sold of $120,063,750 · 14 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $68.5M from 14 investors (100% of the $68.5M target) as of the latest filing. Michael is listed as director, executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(c) (163 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SB
Biotechnology

SPRUCE BIOSCIENCES, INC.

South San Francisco, CA · Feb 28, 2020 → Oct 17, 2025 · 4 filings
  • Oct 17, 2025 · D · $49,999,768 sold of $49,999,768 · 21 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 28, 2023 · D · $53,615,720 sold of $53,615,720 · 20 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Aug 14, 2020 · D/A · $88,000,000 sold of $88,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 28, 2020 · D · $44,000,000 sold of $88,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $88M from 21 investors (100% of the $50M target) as of the latest filing. Michael is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

P
Biotechnology

Plexium, Inc.

San Diego, CA · Aug 25, 2025
  • Aug 25, 2025 · D · $60,115,703 sold of $60,115,703 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60.1M from 20 investors (100% of the $60.1M target) as of the latest filing. Michael is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

OT
Pharmaceuticals · group: Onkure

OnKure Therapeutics, Inc.

Boulder, CO · Jan 8, 2018 → Oct 21, 2024 · 4 filings
  • Oct 21, 2024 · D · $65,000,000 sold of $65,000,000 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 21, 2020 · D · $47,384,999 sold of $94,769,998 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 14, 2019 · D · $25,000,002 sold of $25,000,002 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 8, 2018 · D · $21,994,682 sold of $51,994,684 · 16 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $65M from 20 investors (100% of the $65M target) as of the latest filing. Michael is listed as director, executive officer on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SP
Biotechnology

Sorriso Pharmaceuticals, Inc.

Sandy, UT · Jan 11, 2022
  • Jan 11, 2022 · D · $21,293,856 sold of $31,390,009 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $21.3M from 11 investors (68% of the $31.4M target) as of the latest filing. Michael is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals

Amplyx Pharmaceuticals, Inc.

San Diego, CA · Nov 12, 2015 → Jan 9, 2020 · 4 filings
  • Jan 9, 2020 · D/A · $91,326,103 sold of $102,736,838 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 1, 2017 · D · $40,042,102 sold of $66,736,837 · 26 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 24, 2015 · D/A · $23,727,051 sold of $49,187,346 · 25 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 12, 2015 · D · $20,000,000 sold of $47,000,000 · 24 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $91.3M from 28 investors (89% of the $102.7M target) as of the latest filing. Michael is listed as director, executive officer on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

BT
Biotechnology

Balance Therapeutics, Inc.

San Bruno, CA · Mar 19, 2015 → May 19, 2015 · 3 filings
  • May 19, 2015 · D · $183,106 sold of $183,106 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 5, 2015 · D · $3,000,000 sold of $3,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 19, 2015 · D · $17,982,388 sold of $17,982,388 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $18M from 22 investors (100% of the $183K target) as of the latest filing. Michael is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

LP
Pharmaceuticals

Lumena Pharmaceuticals, Inc.

San Diego, CA · Feb 17, 2011 → Mar 19, 2014 · 5 filings
  • Mar 19, 2014 · D · $45,499,993 sold of $45,499,993 · 13 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • May 24, 2012 · D/A · $2,550,150 sold of $2,550,150 · 6 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 8, 2012 · D/A · $2,550,000 sold of $2,550,000 · 6 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 16, 2011 · D/A · $500,000 sold of $2,000,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 17, 2011 · D · $250,000 sold of $500,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $45.5M from 13 investors (100% of the $45.5M target) as of the latest filing. Michael is listed as executive officer, director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

HP
Pharmaceuticals

HORIZON PHARMA, INC.

Deerfield, IL · Mar 8, 2012 → Dec 9, 2013 · 3 filings
  • Dec 9, 2013 · D · $150,000,000 sold of $150,000,000 · 74 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 19, 2012 · D · $65,934,397 sold of $65,934,397 · 32 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 8, 2012 · D · $32,772 sold of $32,772 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $150M from 74 investors (100% of the $150M target) as of the latest filing. Michael is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Pharmaceuticals

Auspex Pharmaceuticals, Inc.

La Jolla, CA · Aug 3, 2009
  • Aug 3, 2009 · D · $3,000,000 sold of $3,000,000 · 7 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $28M from 9 investors (100% of the $3M target) as of the latest filing. Michael is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Michael Grey — CT, 1 issuer, Aug 23, 2010 → Aug 23, 2010 · no shared issuer
  • Michael Grey — MA, 1 issuer, Nov 29, 2011 → Nov 29, 2011 · no shared issuer

People around Michael 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Mathers

Director · 6 shared filings (5 issuers) · also on 2 other issuers

Edward Mathers is on 7 issuers in total — a repeat sponsor. Their page lists every one.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Ed Mathers

Director · 6 shared filings (3 issuers) · also on 10 other issuers

Ed Mathers is on 13 issuers in total — a repeat sponsor. Their page lists every one.

TA
No photo found yet (own website and image search run after this page is viewed)
Person

Tiba Aynechi

Director · 5 shared filings (2 issuers) · also on 9 other issuers

Tiba Aynechi is on 11 issuers in total — a repeat sponsor. Their page lists every one.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Bali Muralidhar

Director · 5 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

CK
No photo found yet (own website and image search run after this page is viewed)
Person

Ciara Kennedy

Executive Officer, Director · 5 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy P. Walbert

Executive Officer, Director · 4 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

FW
No photo found yet (own website and image search run after this page is viewed)
Person

Ford S. Worthy

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

EH
No photo found yet (own website and image search run after this page is viewed)
Person

Elaine Heron

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

NO
No photo found yet (own website and image search run after this page is viewed)
Person

Niall ODonnell

Director · 4 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

ND
No photo found yet (own website and image search run after this page is viewed)
Person

Niall O'Donnell

Executive Officer, Director · 4 shared filings (3 issuers) · also on 9 other issuers

Niall O'Donnell is on 12 issuers in total — a repeat sponsor. Their page lists every one.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Chin

Director · 3 shared filings (1 issuer) · also on 4 other issuers

Richard Chin is on 5 issuers in total — a repeat sponsor. Their page lists every one.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

Peter Carlton

Director · 3 shared filings (1 issuer) · also on 16 other issuers

Peter Carlton is on 17 issuers in total — a repeat sponsor. Their page lists every one.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Samir Gharib

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Himawan

Director · 3 shared filings (1 issuer) · also on 5 other issuers

Jeff Himawan is on 6 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey W. Bird

Director · 3 shared filings (1 issuer) · also on 10 other issuers

Jeffrey W. Bird is on 11 issuers in total — a repeat sponsor. Their page lists every one.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald Pauli

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

WJ
No photo found yet (own website and image search run after this page is viewed)
Person

Wendy Johnson

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

RV
No photo found yet (own website and image search run after this page is viewed)
Person

Robert De Vaere

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

PW
No photo found yet (own website and image search run after this page is viewed)
Person

Phyllis E. Whiteley

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

JF
No photo found yet (own website and image search run after this page is viewed)
Person

Jean-Francois Formela

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Rosina Maar Pavia

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

Gino Santini

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Susan Dube

Executive Officer · 3 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

John P. McKearn

Director · 3 shared filings (1 issuer) · also on 16 other issuers

John P. McKearn is on 17 issuers in total — a repeat sponsor. Their page lists every one.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Lyndon Lien

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

DINA CHAYA

Director · 3 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

PH
No photo found yet (own website and image search run after this page is viewed)
Person

Patrick Heron

Director · 3 shared filings (1 issuer) · also on 33 other issuers

Patrick Heron is on 34 issuers in total — a repeat sponsor. Their page lists every one.

KW
No photo found yet (own website and image search run after this page is viewed)
Person

Kirk Ways

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Javier Szwarcberg

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

SC
No photo found yet (own website and image search run after this page is viewed)
Person

Simpson Camilla

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

LB
No photo found yet (own website and image search run after this page is viewed)
Person

Louis C. Bock

Director · 2 shared filings (1 issuer) · also on 8 other issuers

Louis C. Bock is on 9 issuers in total — a repeat sponsor. Their page lists every one.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Anand Mehra

Director · 2 shared filings (1 issuer) · also on 7 other issuers

Anand Mehra is on 8 issuers in total — a repeat sponsor. Their page lists every one.

PG
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Grint

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Paul Grint is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard King

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

DANIEL K. SPIEGELMAN

Director · 2 shared filings (1 issuer) · also on 4 other issuers

DANIEL K. SPIEGELMAN is on 5 issuers in total — a repeat sponsor. Their page lists every one.

TG
No photo found yet (own website and image search run after this page is viewed)
Person

Ted Greene

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

EG
No photo found yet (own website and image search run after this page is viewed)
Person

Edward E. Greene

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

JONAS HANSSON

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Grey. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mitchell Mutz

Executive Officer · 2 shared filings (1 issuer) · also on 5 other issuers

Mitchell Mutz is on 6 issuers in total — a repeat sponsor. Their page lists every one.

ND
No photo found yet (own website and image search run after this page is viewed)
Person

Niall O'Donnell, Ph.D.

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Grey. Their page shows their other deals.

The team behind the deals

O
Sponsor group

Onkure

2 issuers · 18 filings · $118.8M reported sold · 2011–2024

One team, 2 deal companies. Michael Grey is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Michael Grey.

Same business address

35 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Michael Grey by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Michael Grey is listed on: none on file. No website or social profile named in Plexium, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #61,904 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗North Carolina eCourts portal ↗Cook County Clerk of Court case search ↗Utah state courts — find the court ↗Colorado state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗North Carolina Secretary of State business search ↗Illinois Secretary of State business search ↗Utah Secretary of State business search ↗Colorado Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Michael Grey appears on a new Form D, or when a court case or SEC action is matched to them. See plans →